Preparation for treating psychosis

A psychiatric and preparation technology, applied in nervous system diseases, medical preparations containing active ingredients, organic active ingredients, etc., can solve the problems of low cure rate, full onset effect, long medication cycle, etc. Fast-acting, eliminates adverse side effects

Inactive Publication Date: 2017-12-15
孙永丽 +1
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the product has a full effect, a long medication cycle, a low cure rate, and side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0014] Preparations for the treatment of psychosis, consisting of the following components:

[0015] Clonazepam 1 mg, Olanzapine 1 mg, Rispridone 1 mg, Cannabichromene 0.5 mg, Succinic Acid 0.5 mg, Fumaric Acid 0.5 mg, Benzoic Acid 0.5 mg, Sorbic Acid 0.5 mg, Glycine Transporter Protein inhibitor 0.25 mg, α7 nicotinic agonist 0.25 mg.

Embodiment 2

[0017] Preparations for the treatment of psychosis, consisting of the following components:

[0018] Clonazepam 2 mg, Olanzapine 2 mg, Rispridone 2 mg, Cannabicycline 1 mg, Succinic Acid 1 mg, Fumaric Acid 1 mg, Benzoic Acid 1 mg, Sorbic Acid 1 mg, Glycine Transporter Protein inhibitor 0.5 mg, α7 nicotinic agonist 0.5 mg.

Embodiment 3

[0020] Preparations for the treatment of psychosis, consisting of the following components:

[0021] Clonazepam 1.5 mg, Olanzapine 1.5 mg, Rispridone 1.5 mg, Cannabichromene 1 mg, Succinic Acid 0.5 mg, Fumaric Acid 0.5 mg, Benzoic Acid 0.5 mg, Sorbic Acid 0.5 mg, Glycine Transporter Protein inhibitor 0.25 mg, α7 nicotinic agonist 0.25 mg.

[0022] By adopting the above-mentioned components of the present invention, it can not only prevent and treat mental diseases and mental disorders, but also reduce or eliminate the adverse side effects of drugs in the second stage, and at the same time, improve the curative effect of drugs, with quick onset and short medication cycle.

[0023] After being used in 100 cases of clinical patients, the effective rate is 100%, the cure rate is 97%, and it takes effect 30 minutes after taking the medicine, with quick onset and short medication cycle.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a preparation for treating psychosis. The preparation is composed of the following components: 1-2mg of clonazepam, 1-2mg of olanzapine, 1-2mg of risperidone, 0.5-1mg of cannabinoid, 0.5-1mg of succinic acid, 0.5-1mg of fumaric acid, 0.5-1mg of benzoic acid, 0.5-1mg of sorbic acid, 0.25-0.5mg of a glycine transporter inhibitor and 0.25-0.5mg of a7 nicotine agonist. The preparation has the advantages that the preparation is especially suitable for the psychopath suffering from the symptoms, such as, manic feel, abnormal laughing and weeping, actions of destroying objects and hurting people, allophasis, insomnia, anorexia, skepticism and depression, is capable of quickly becoming effective and is short in medicine-taking period.

Description

technical field [0001] The invention relates to a medicine, in particular to a preparation for treating psychosis, and belongs to the field of medicine. Background technique [0002] Symptoms of mental diseases include schizophrenia caused by brain dysfunction, various complex social and psychological factors and various aspects of work pressure. Excessive thinking, trance, hallucinations and delusions, excitement and agitation, wry smiles, language disorder, withdrawn personality, abnormal emotions, frightened, etc. Mental diseases are mostly caused by disorders of brain function activities, mental disorders, or dysfunction of internal organs caused by various complex social environments, psychological quality and work pressure, and genetic genes can also cause mental disorders. Mental illness. The Chinese invention patent titled "A Black and White Prescription for the Treatment of Psychosis" with the application number "200610072884.7" discloses a black and white prepara...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K45/06A61K31/5513A61P25/18A61K31/19A61K31/192A61K31/194A61K31/352A61K31/519A61K31/551
CPCA61K45/06A61K31/19A61K31/192A61K31/194A61K31/352A61K31/519A61K31/551A61K31/5513A61K2300/00
Inventor 孙永丽李丽
Owner 孙永丽
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products